| 货号 |
中文名 |
英文名 |
品牌 |
规格 |
价格 |
详细 |
| D256-20ug |
Anti-Human DAPK2 Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DAPK2 |
Leinco |
20μg |
2248 |
More |
| D257-0.1 mg |
Anti-Human DRAK1 (NT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DRAK1 (NT) |
Leinco |
0.1mg |
8602 |
More |
| D257-20ug |
Anti-Human DRAK1 (NT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DRAK1 (NT) |
Leinco |
20μg |
1857 |
More |
| D258-0.1 mg |
Anti-Human DRAK2 (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DRAK2 (CT) |
Leinco |
0.1mg |
8602 |
More |
| D258-20ug |
Anti-Human DRAK2 (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DRAK2 (CT) |
Leinco |
20μg |
1857 |
More |
| D259-0.1 mg |
Anti-Human Daxx (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human Daxx (CT) |
Leinco |
0.1mg |
8602 |
More |
| D259-20ug |
Anti-Human Daxx (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human Daxx (CT) |
Leinco |
20μg |
1857 |
More |
| D260-50ml |
In vivo Antibody Diluent pH 7.2 with 0.01% Polysorbate 80 Leinco-北京博迈斯科技发展有限公司 |
In vivo Antibody Diluent pH 7.2 with 0.01% Polysorbate 80 |
Leinco |
50 ml |
1096 |
More |
| D261-50 μg |
DAP kinase 2 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DAP kinase 2 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D262-50 μg |
Daxx (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
Daxx (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D263-50 μg |
TRAIL R3 (Extracellular Domain - 1) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
TRAIL R3 (Extracellular Domain - 1) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D265-50 μg |
TRAIL R3 (Extracellular Domain - 2) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
TRAIL R3 (Extracellular Domain - 2) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D266-50 μg |
TRAIL R4 (Intracellular Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
TRAIL R4 (Intracellular Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D267-50 μg |
DcR3 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DcR3 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D268-50 μg |
DFF40 (Intermediate Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DFF40 (Intermediate Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D269-50 μg |
DFF40 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DFF40 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D270-50 μg |
DFF40 (I18) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DFF40 (I18) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D271-50 μg |
DFF45 (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DFF45 (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D272-50 μg |
DFF45/35 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DFF45/35 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D273-50 μg |
DNase II (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DNase II (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D274-50 μg |
DR3 (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DR3 (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D275-50 μg |
DR3 (Extracellular Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DR3 (Extracellular Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D276-50 μg |
DR3 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DR3 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D277-50 μg |
TRAIL Receptor-1 (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
TRAIL Receptor-1 (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D278-50 μg |
TRAIL Receptor-1 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
TRAIL Receptor-1 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D279-50 μg |
DR5 (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DR5 (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D280-50 μg |
DR6 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DR6 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D281-50 μg |
DRAK1 (NT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DRAK1 (NT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D282-50 μg |
DRAK2 (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DRAK2 (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D283-0.1 mg |
Anti-Human DR3 (Extracellular Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DR3 (Extracellular Domain) |
Leinco |
0.1mg |
8602 |
More |
| D283-20ug |
Anti-Human DR3 (Extracellular Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DR3 (Extracellular Domain) |
Leinco |
20μg |
1857 |
More |
| D284-0.1 mg |
Anti-Human DEDAF Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DEDAF |
Leinco |
0.1mg |
8602 |
More |
| D284-20ug |
Anti-Human DEDAF Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DEDAF |
Leinco |
20μg |
1857 |
More |
| D285-50 μg |
DEDAF Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DEDAF Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D286-0.1 mg |
Anti-Human DC-SIGN (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DC-SIGN (CT) |
Leinco |
0.1mg |
8602 |
More |
| D286-20ug |
Anti-Human DC-SIGN (CT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DC-SIGN (CT) |
Leinco |
20μg |
1857 |
More |
| D287-50 μg |
DC-SIGN (CT) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DC-SIGN (CT) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D288-0.1 mg |
Anti-Human DC-SIGN (ED) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DC-SIGN (ED) |
Leinco |
0.1mg |
8602 |
More |
| D288-20ug |
Anti-Human DC-SIGN (ED) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DC-SIGN (ED) |
Leinco |
20μg |
1857 |
More |
| D289-50 μg |
DC-SIGN (Extracellular Domain) Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DC-SIGN (Extracellular Domain) Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D311-0.1 mg |
Human Duodenum Tissue Lysate Leinco-北京博迈斯科技发展有限公司 |
Human Duodenum Tissue Lysate |
Leinco |
0.1mg |
3592 |
More |
| D314-0.1 mg |
Anti-Human DAD1 Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DAD1 |
Leinco |
0.1mg |
8602 |
More |
| D314-20ug |
Anti-Human DAD1 Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DAD1 |
Leinco |
20μg |
1857 |
More |
| D315-0.1 mg |
Anti-Human DEDD2 Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DEDD2 |
Leinco |
0.1mg |
8602 |
More |
| D315-20ug |
Anti-Human DEDD2 Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DEDD2 |
Leinco |
20μg |
1857 |
More |
| D316-50 μg |
DAD1 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DAD1 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D324-50 μg |
DEDD2 Blocking Peptide Leinco-北京博迈斯科技发展有限公司 |
DEDD2 Blocking Peptide |
Leinco |
50μg |
2150 |
More |
| D325-0.1 mg |
Anti-Human DDX3 (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DDX3 (Intermediate Domain) |
Leinco |
0.1mg |
8602 |
More |
| D325-20ug |
Anti-Human DDX3 (Intermediate Domain) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DDX3 (Intermediate Domain) |
Leinco |
20μg |
1857 |
More |
| D326-0.1 mg |
Anti-Human DDX3 (NT) Leinco-北京博迈斯科技发展有限公司 |
Anti-Human DDX3 (NT) |
Leinco |
0.1mg |
8602 |
More |
